Private Equity Firms in India Drive Growth in Healthcare & MedTech

Quadria Capital is a top firms in the Asian healthcare investment sector. Quadria Capital one of the leading private equity fund/funds provider companies in India, Singapore, Malaysia with assets under management exceeding US$ 1.5 billion and investments in 18 companies across the Asia-Pacific region.
The healthcare industry in India is growing at a rapid pace
at a CAGR of 22% since 2016. At this rate, it is expected to reach USD 372
Billion in 2022. It provides direct employment opportunities to 4.7 million
people and the sector has the potential to create 2.7 million additional jobs
by the year 2022.
India is considered as one of the fastest-growing healthcare
markets worldwide and is giving a fillip to the positive investment sentiment
in this sector. Given the opportunities and significant RoI the sector is
offering, private equity funds in India have
been aggressively making its ways towards the healthcare sector.
Indian healthcare industry mainly consists of hospitals,
medical devices and equipment, health insurance, clinical trials, telemedicine,
and medical tourism. These market segments are expected to diversify as an
aging population with a growing middle class increasingly favors preventative
healthcare. Besides, the rising number of lifestyle-related diseases is
boosting demand for specialized care services.
Apart from these, COVID-19 is likely to catalyze long-term
changes in attitudes towards personal health and hygiene, health insurance,
fitness, and nutrition as well as health monitoring and medical check-ups. The
pandemic has also accelerated the adoption of digital technologies, including
telemedicine.
Further, there is a growing emphasis on and the emergence of
Public-Private Partnership models in India’s healthcare sector. The country’s
relative cost competitiveness and availability of skilled labor are also making
it an increasingly favored destination for medical tourism.
Talking about the policy, the Indian Government is
undertaking deep structural and sustained reforms to strengthen the healthcare
sector; it has also announced conducive policies for encouraging Foreign Direct
Investment (FDI). India’s FDI regime has been liberalized extensively.
·
Currently, FDI is permitted up to 100% under the
automatic route in the hospital sector and the manufacture of medical devices.
·
In the
pharmaceutical sector, FDI is permitted up to 100% in Greenfield projects and
74% in Brownfield projects under the automatic route.
According to a report by NITI Aayog, India has emerged as one of the fastest-growing emerging economies over
the last two decades, receiving large FDI inflows, which have grown from USD
2.5 Billion in 2000-01 to USD 50 Billion in 2019-20. The healthcare sector, in
particular, has received heightened interest from investors over the last few
years, with the transaction value increasing from USD 94 Million (2011) to USD
1,275 Million (2016) – a jump of over 13.5 times.
Comments
Post a Comment